You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Skip to main navigation
Skip to main content
Turn on more accessible mode
Turn off more accessible mode
Sign In
This site uses cookies to help us give you the best experience on our website. To find out more about the cookies we use, read our
Terms and Conditions
Hide This
Search
Advanced Search
Sign up to e-alerts
Home
Currently selected
About us
Who we are and what we do
The Code
Interactive Code 2016
Interactive Code 2015
Interactive Code 2014
Advice
Appeal Procedures
Supply of emollients for patients to try
Third party service providers, ABPI membership and the Code
Cases
Ongoing cases
Completed cases
Code of Practice Reviews
Corrective statements
Advertisements and public reprimands
Media
News archive
Training
News articles
Currently selected
Advanced Search
Sign up to e-alerts
Search
Home
Currently selected
About us
The Code
Advice
Cases
Media
Training
Contact Us
Site Map
Sign up to e-alerts
PMCPA
>
News articles
News articles
Currently selected
E-learning module for health professionals
Read more
News articles
Page Content
New disclosure template for 2018 data submissions
New disclosure template for 2018 data submissions
Read more
ABPI Code of Practice for the Pharmaceutical Industry 2019 published
Read more
PMCPA Annual Report 2017
Read more
Thame Laboratories named in advertisement for breach of ABPI Code of Practice and required to issue a corrective statement
Press Release
Read more
Launch of consultation on proposals to change ABPI Code of Practice for the Pharmaceutical Industry
The Consultation closed on 10th October 2018. Many thanks to those who contributed.
Read more
Martindale Pharma, Pierre Fabre, Janssen and Pharmasure have been named in advertisements(1) following breaches of the ABPI Code of Practice for the Pharmaceutical Industry. In addition Pierre Fabre was publicly reprimanded.
Press Release All four companies have brought discredit upon, and reduced confidence in, the pharmaceutical industry.
Read more
UCB and PharmaMar have been named in advertisements following breaches of the ABPI Code of Practice and PharmaMar has been publicly reprimanded and required to issue a corrective statement.
Press Release
Read more
Signatories
Read more
Guidance on Appeal Procedures
Guidance on Appeal Procedures January 2016
Read more
Joint Letter from ABPI and NHS England about Disclosure
Read more
Page Content 2
